Titan Pharmaceuticals Inc (TTNP)

[rikshot]

The annual meeting of stockholders of Titan Pharmaceuticals, Inc. (“our company, “Titan,” “we,” “our,” or
“us”) will be held at our executive offices at 400 Oyster Point Boulevard, Suite 505, South San Francisco,
California 94080 on Tuesday, August 7, 2018 at 9:00 a.m. local time for the following purposes:

• to elect a board of eight directors;

• to approve an amendment to our 2015 Omnibus Equity Incentive Plan to increase the number of shares
of common stock reserved for awards from 2,500,000 to 3,500,000;

• to ratify the appointment of OUM & Co. LLP as our independent registered public accounting firm for
the fiscal year ending December 31, 2018; and

• to consider and take action upon such other matters as may properly come before the meeting or any
adjournment thereo